These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 33465342)

  • 21. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.
    Klok FA; Kruip MJHA; van der Meer NJM; Arbous MS; Gommers D; Kant KM; Kaptein FHJ; van Paassen J; Stals MAM; Huisman MV; Endeman H
    Thromb Res; 2020 Jul; 191():148-150. PubMed ID: 32381264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: The Padua province experience.
    Pesavento R; Ceccato D; Pasquetto G; Monticelli J; Leone L; Frigo A; Gorgi D; Postal A; Marchese GM; Cipriani A; Saller A; Sarais C; Criveller P; Gemelli M; Capone F; Fioretto P; Pagano C; Rossato M; Avogaro A; Simioni P; Prandoni P; Vettor R
    J Thromb Haemost; 2020 Oct; 18(10):2629-2635. PubMed ID: 32692874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Standard-Dose Prophylactic, High-Dose Prophylactic, and Therapeutic Anticoagulation in Patients With Hypoxemic COVID-19 Pneumonia: The ANTICOVID Randomized Clinical Trial.
    Labbé V; Contou D; Heming N; Megarbane B; Razazi K; Boissier F; Ait-Oufella H; Turpin M; Carreira S; Robert A; Monchi M; Souweine B; Preau S; Doyen D; Vivier E; Zucman N; Dres M; Fejjal M; Noel-Savina E; Bachir M; Jaffal K; Timsit JF; Picos SA; Mariotte E; Martis N; Juguet W; Melica G; Rondeau P; Audureau E; Mekontso Dessap A;
    JAMA Intern Med; 2023 Jun; 183(6):520-531. PubMed ID: 36946232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
    Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
    Thromb Res; 2020 Dec; 196():313-317. PubMed ID: 32977129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombotic complications and anticoagulation in COVID-19 pneumonia: a New York City hospital experience.
    Hanif A; Khan S; Mantri N; Hanif S; Saleh M; Alla Y; Chinta S; Shrestha N; Ji W; Attwood K; Adrish M; Jain KR
    Ann Hematol; 2020 Oct; 99(10):2323-2328. PubMed ID: 32808105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dialysis circuit clotting in critically ill patients with COVID-19 infection.
    Khoo BZE; Lim RS; See YP; Yeo SC
    BMC Nephrol; 2021 Apr; 22(1):141. PubMed ID: 33879086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venous Thromboembolism in Hospitalized COVID-19 Patients.
    Sridharan GK; Vegunta R; Rokkam VRP; Meyyur Aravamudan V; Vegunta R; Khan SR; Ponnada S; Boregowda U; Prudhvi K; Chamarthi G; Mohan BP
    Am J Ther; 2020; 27(6):e599-e610. PubMed ID: 33156016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week.
    Farkouh ME; Stone GW; Lala A; Bagiella E; Moreno PR; Nadkarni GN; Ben-Yehuda O; Granada JF; Dressler O; Tinuoye EO; Granada C; Bustamante J; Peyra C; Godoy LC; Palacios IF; Fuster V
    J Am Coll Cardiol; 2022 Mar; 79(9):917-928. PubMed ID: 35241226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT Study.
    Akinosoglou K; Savopoulos C; Pouliakis A; Triantafyllidis C; Markatis E; Golemi F; Liontos A; Vadala C; Papanikolaou IC; Dimakopoulou V; Xarras P; Varela K; Kaiafa G; Mitsianis A; Chatzistamati A; Randou E; Savvanis S; Pavlaki M; Efraimidis G; Samaras V; Papazoglou D; Konstantinidou A; Panagopoulos P; Milionis H; On Behalf Of The Interact Study Group
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulation strategy and safety in critically ill COVID-19 patients: a French retrospective multicentre study.
    Lamouche-Wilquin P; Perrin L; Pere M; Raymond M; Asfar P; Darreau C; Reizine F; Colin G; Delbove A; Auchabie J; Hourmant B; Frérou A; Combe B; Morin J; Kergoat P; Lorber J; Egreteau PY; Souchard J; Canet E; Lascarrou JB
    Thromb J; 2023 Apr; 21(1):42. PubMed ID: 37072788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 Infection in Critically Ill Patients Carries a High Risk of Venous Thrombo-embolism.
    Bellmunt-Montoya S; Riera C; Gil D; Rodríguez M; García-Reyes M; Martínez-Carnovale L; Marrero C; Gil M; Ruiz-Rodríguez JC; Ferrer R; de Nadal M; Monreal M; Llagostera S
    Eur J Vasc Endovasc Surg; 2021 Apr; 61(4):628-634. PubMed ID: 33583710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Report of Low Incidence of Thrombosis with Early Prophylaxis in Hospitalized Patients with COVID-19 from Two Saudi Tertiary Centers.
    Owaidah T; Maghrabi K; Alfraih F; Haroon A; Siddiqui K; Alnounou R; AlOtair H; Alqahtany FS; Maghrabi M; Owaidah M; AlSaleh K
    Clin Appl Thromb Hemost; 2022; 28():10760296221086286. PubMed ID: 35311592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deep vein thrombosis in hospitalized patients with coronavirus disease 2019.
    Chang H; Rockman CB; Jacobowitz GR; Speranza G; Johnson WS; Horowitz JM; Garg K; Maldonado TS; Sadek M; Barfield ME
    J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):597-604. PubMed ID: 33039545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late-onset of pulmonary embolism following hospitalization for COVID-19 despite thromboprophylaxis: a report of two cases.
    Brem FL; Missaoui Z; Arghal M; Rasras H; Aichouni N; Skiker I; Ouafi NE; Zakaria B
    Pan Afr Med J; 2021; 38():226. PubMed ID: 34046131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
    Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
    Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19.
    Patell R; Bogue T; Bindal P; Koshy A; Merrill M; Aird WC; Bauer KA; Zwicker JI
    J Thromb Haemost; 2020 Sep; 18(9):2349-2357. PubMed ID: 32692862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
    Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
    Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic versus therapeutic dose anticoagulation effects on survival among critically ill patients with COVID-19.
    Hoogenboom WS; Lu JQ; Musheyev B; Borg L; Janowicz R; Pamlayne S; Hou W; Duong TQ
    PLoS One; 2022; 17(1):e0262811. PubMed ID: 35045130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
    ; ; ; Goligher EC; Bradbury CA; McVerry BJ; Lawler PR; Berger JS; Gong MN; Carrier M; Reynolds HR; Kumar A; Turgeon AF; Kornblith LZ; Kahn SR; Marshall JC; Kim KS; Houston BL; Derde LPG; Cushman M; Tritschler T; Angus DC; Godoy LC; McQuilten Z; Kirwan BA; Farkouh ME; Brooks MM; Lewis RJ; Berry LR; Lorenzi E; Gordon AC; Ahuja T; Al-Beidh F; Annane D; Arabi YM; Aryal D; Baumann Kreuziger L; Beane A; Bhimani Z; Bihari S; Billett HH; Bond L; Bonten M; Brunkhorst F; Buxton M; Buzgau A; Castellucci LA; Chekuri S; Chen JT; Cheng AC; Chkhikvadze T; Coiffard B; Contreras A; Costantini TW; de Brouwer S; Detry MA; Duggal A; Džavík V; Effron MB; Eng HF; Escobedo J; Estcourt LJ; Everett BM; Fergusson DA; Fitzgerald M; Fowler RA; Froess JD; Fu Z; Galanaud JP; Galen BT; Gandotra S; Girard TD; Goodman AL; Goossens H; Green C; Greenstein YY; Gross PL; Haniffa R; Hegde SM; Hendrickson CM; Higgins AM; Hindenburg AA; Hope AA; Horowitz JM; Horvat CM; Huang DT; Hudock K; Hunt BJ; Husain M; Hyzy RC; Jacobson JR; Jayakumar D; Keller NM; Khan A; Kim Y; Kindzelski A; King AJ; Knudson MM; Kornblith AE; Kutcher ME; Laffan MA; Lamontagne F; Le Gal G; Leeper CM; Leifer ES; Lim G; Gallego Lima F; Linstrum K; Litton E; Lopez-Sendon J; Lother SA; Marten N; Saud Marinez A; Martinez M; Mateos Garcia E; Mavromichalis S; McAuley DF; McDonald EG; McGlothlin A; McGuinness SP; Middeldorp S; Montgomery SK; Mouncey PR; Murthy S; Nair GB; Nair R; Nichol AD; Nicolau JC; Nunez-Garcia B; Park JJ; Park PK; Parke RL; Parker JC; Parnia S; Paul JD; Pompilio M; Quigley JG; Rosenson RS; Rost NS; Rowan K; Santos FO; Santos M; Santos MO; Satterwhite L; Saunders CT; Schreiber J; Schutgens REG; Seymour CW; Siegal DM; Silva DG; Singhal AB; Slutsky AS; Solvason D; Stanworth SJ; Turner AM; van Bentum-Puijk W; van de Veerdonk FL; van Diepen S; Vazquez-Grande G; Wahid L; Wareham V; Widmer RJ; Wilson JG; Yuriditsky E; Zhong Y; Berry SM; McArthur CJ; Neal MD; Hochman JS; Webb SA; Zarychanski R
    N Engl J Med; 2021 Aug; 385(9):777-789. PubMed ID: 34351722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence & outcomes of clinically significant bleeding events in critically ill COVID-19 patients receiving Therapeutic dose AntiCoagulanTs: A retrospective cohort study (INTerACT study).
    Singh A; Dhir A; Kajal K; Naik NB; Lazar MS; Puri GD; Soni SL; Neupane A; Ganesh V; Kaloria N; Saini K; Hazarika A; Mahajan V; Singla K; Bhalla A
    Indian J Med Res; 2022; 155(5&6):526-537. PubMed ID: 36124497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.